Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
The Lancet Neurology
Fecha de publicación: 10 February 2020
DOI: https://doi.org/10.1016/S1474-4422(19)30488-0
Autores: Thaís Armangue, MD., Gemma Olivé-Cirera, MD., Eugenia Martínez-Hernandez, MD., Maria Sepulveda, MD.,
Raquel Ruiz-Garcia, PhD., Marta Muñoz-Batista, BS., et al.
Background: Investigations of myelin oligodendrocyte glycoprotein (MOG) antibodies are usually focused on demyelinating syndromes, but the entire spectrum of MOG antibody-associated syndromes in children is unknown. In this study, we aimed to determine the frequency and distribution of paediatric demyelinating and encephalitic syndromes with MOG antibodies, their response to treatment, and the phenotypes associated with poor prognosis.
